CD1 and mycobacterial lipids activate human T cells

Immunological Reviews

Volumn 264, Issue 1, 2015, Pages 138-153

  Van Rhijn, Ildiko ^a,b   Moody, D Branch ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

CD1; Mycobacterium tuberculosis; Mycolyl lipids; T cells; T cell receptor

Indexed keywords

CD1 ANTIGEN; EPITOPE; LIPID; LIPOPEPTIDE; MYCOBACTERIAL LIPID; MYCOBACTERIUM ANTIGEN; MYCOKETIDE ANTIGEN; MYCOLYL LIPID ANTIGEN; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL MANNOSIDE ANTIGEN; PHOSPHOLIPID; SULFOLIPID ANTIGEN; T LYMPHOCYTE ANTIGEN; TETRAMER; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN;

ADAPTIVE IMMUNITY; ANTIGEN BINDING; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELL FUNCTION; CROSS REACTION; DENDRITIC CELL; ENDOPLASMIC RETICULUM; ENDOSOME; GENE CONTROL; GENE EXPRESSION; GERMLINE ENCODED MYCOLYL REACTIVE; HOST; HUMAN; IMMUNE EVASION; IMMUNOGENETICS; IMMUNOTHERAPY; MAJOR HISTOCOMPATIBILITY COMPLEX; MAMMAL; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER T CELL; NONHUMAN; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; SECRETORY PATHWAY; SEQUENCE HOMOLOGY; SERODIAGNOSIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS; ANIMAL; ANTIBODY SPECIFICITY; CHEMISTRY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LIPID METABOLISM; LYMPHOCYTE ACTIVATION; METABOLISM; MICROBIOLOGY; PROTEIN MULTIMERIZATION; T LYMPHOCYTE SUBPOPULATION; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, BACTERIAL; ANTIGENS, CD1; BIOLOGICAL TRANSPORT; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; ENDOSOMES; EPITOPES; GENE EXPRESSION REGULATION; HUMANS; LIPID METABOLISM; LIPIDS; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM TUBERCULOSIS; ORGAN SPECIFICITY; PHOSPHOLIPIDS; PROTEIN MULTIMERIZATION; T-LYMPHOCYTE SUBSETS; TUBERCULOSIS;

EID: 84923208184     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12253     Document Type: Article

References (145)

1. Russell DG, Mwandumba HC, Rhoades EE. Mycobacterium and the coat of many lipids. J Cell Biol 2002;158:421-426.
2. Brightbill HD, et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999;285:732-736.
3. Ishikawa E, et al. Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J Exp Med 2009;206:2879-2888.
4. Geisel RE, Sakamoto K, Russell DG, Rhoades ER. In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette-Guerin is due principally to trehalose mycolates. J Immunol 2005;174:5007-5015.
5. Porcelli S, Morita CT, Brenner MB. CD1b restricts the response of human CD4-8- T lymphocytes to a microbial antigen. Nature 1992;360:593-597.
6. Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, Brenner MB. Recognition of a lipid antigen by CD1-restricted αβ+ T cells. Nature 1994;372:691-694.
7. Moody DB, et al. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science 1997;278:283-286.
8. Sieling PA, et al. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 1995;269:227-230.
9. Gilleron M, et al. Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis. J Exp Med 2004;199:649-659.
10. Moody DB, et al. T cell activation by lipopeptide antigens. Science 2004;303:527-531.
11. Fowlkes BJ, et al. A novel population of T-cell receptor αβ-bearing thymocytes which predominantly expresses a single V beta gene family. Nature 1987;329:251-254.
12. Van Rhijn I, et al. A conserved human T cell population targets mycobacterial antigens presented by CD1b. Nat Immunol 2013;14:706-713.
13. McMichael AJ, Pilch JR, Galfre G, Mason DY, Fabre JW, Milstein C. A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody. Eur J Immunol 1979;9:205-210.
14. Zeng Z, Castano AR, Segelke BW, Stura EA, Peterson PA, Wilson IA. Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science 1997;277:339-345.
15. Dossa RG, Alperin DC, Hines MT, Hines SA. The equine CD1 gene family is the largest and most diverse yet identified. Immunogenetics 2014;66:33-42.
16. Hayes SM, Knight KL. Group 1 CD1 genes in rabbit. J Immunol 2001;166:403-410.
17. Dascher CC, et al. Conservation of a CD1 multigene family in the guinea pig. J Immunol 1999;163:5478-5488.
18. Van Rhijn I, et al. The bovine CD1 family contains group 1 CD1 proteins, but no functional CD1d. J Immunol 2006;176:4888-4893.
19. Eguchi-Ogawa T, et al. Analysis of the genomic structure of the porcine CD1 gene cluster. Genomics 2007;89:248-261.
20. Looringh van Beeck FA, et al. Two canine CD1a proteins are differentially expressed in skin. Immunogenetics 2008;60:315-324.
21. Nei M, Rooney AP. Concerted and birth-and-death evolution of multigene families. Annu Rev Genet 2005;39:121-152.
22. Hiromatsu K, et al. Characterization of guinea-pig group 1 CD1 proteins. Immunology 2002;106:159-172.
23. Wang C, Perera TV, Ford HL, Dascher CC. Characterization of a divergent non-classical MHC class I gene in sharks. Immunogenetics 2003;55:57-61.
24. Miller MM, et al. Characterization of two avian MHC-like genes reveals an ancient origin of the CD1 family. Proc Natl Acad Sci USA 2005;102:8674-8679.
25. Dascher CC. Evolutionary biology of CD1. Curr Top Microbiol Immunol 2007;314:3-26.
26. Dascher CC, Brenner MB. Evolutionary constraints on CD1 structure: insights from comparative genomic analysis. Trends Immunol 2003;24:412-418.
27. Felio K, et al. CD1-restricted adaptive immune responses to Mycobacteria in human group 1 CD1 transgenic mice. J Exp Med 2009;206:2497-2509.
28. Lockridge JL, et al. Analysis of the CD1 antigen presenting system in humanized SCID mice. PLoS ONE 2011;6:e21701.
29. Dascher CC, et al. Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis. Int Immunol 2003;15:915-925.
30. Hiromatsu K, et al. Induction of CD1-restricted immune responses in guinea pigs by immunization with mycobacterial lipid antigens. J Immunol 2002;169:330-339.
31. Watanabe Y, et al. BCG vaccine elicits both T-cell mediated and humoral immune responses directed against mycobacterial lipid components. Vaccine 2006;24:5700-5707.
32. Nguyen TK, et al. The bovine CD1D gene has an unusual gene structure and is expressed but cannot present α-galactosylceramide with a C26 fatty acid. Int Immunol 2013;25:91-98.
33. Van Rhijn I, et al. Low cross-reactivity of T-cell responses against lipids from Mycobacterium bovis and M. avium paratuberculosis during natural infection. Eur J Immunol 2009;39:3031-3041.
34. Nguyen TK, Koets AP, Santema WJ, van Eden W, Rutten VP, Van Rhijn I. The mycobacterial glycolipid glucose monomycolate induces a memory T cell response comparable to a model protein antigen and no B cell response upon experimental vaccination of cattle. Vaccine 2009;27:4818-4825.
35. Morita D, et al. Trans-species activation of human T cells by rhesus macaque CD1b molecules. Biochem Biophys Res Commun 2008;377:889-893.
36. Porcelli SA. The CD1 family: a third lineage of antigen-presenting molecules. Adv Immunol 1995;59:1-98.
37. Maitre B, et al. The assembly of CD1e is controlled by an N-terminal propeptide which is processed in endosomal compartments. Biochem J 2009;419:661-668.
38. Angenieux C, et al. The cellular pathway of CD1e in immature and maturing dendritic cells. Traffic 2005;6:286-302.
39. de la Salle H, et al. Assistance of microbial glycolipid antigen processing by CD1e. Science 2005;310:1321-1324.
40. Facciotti F, et al. Fine tuning by human CD1e of lipid-specific immune responses. Proc Natl Acad Sci USA 2011;108:14228-14233.
41. Calabi F, Milstein C. A novel family of human major histocompatibility complex-related genes not mapping to chromosome 6. Nature 1986;323:540-543.
42. Dougan SK, Kaser A, Blumberg RS. CD1 expression on antigen-presenting cells. Curr Top Microbiol Immunol 2007;314:113-141.
43. Schenk M, et al. NOD2 triggers an interleukin-32-dependent human dendritic cell program in leprosy. Nat Med 2012;18:555-563.
44. Krutzik SR, et al. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat Med 2005;11:653-660.
45. Somnay-Wadgaonkar K, et al. Immunolocalization of CD1d in human intestinal epithelial cells and identification of a beta2-microglobulin-associated form. Int Immunol 1999;11:383-392.
46. Calabi F, Jarvis JM, Martin L, Milstein C. Two classes of CD1 genes. Eur J Immunol 1989;19:285-292.
47. Yakimchuk K, et al. Borrelia burgdorferi infection regulates CD1 expression in human cells and tissues via IL1-beta. Eur J Immunol 2011;41:694-705.
48. Roura-Mir C, et al. Mycobacterium tuberculosis regulates CD1 antigen presentation pathways through TLR-2. J Immunol 2005;175:1758-1766.
49. Moody DB. TLR gateways to CD1 function. Nat Immunol 2006;7:811-817.
50. Sieling PA, et al. CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity. J Immunol 1999;162:1851-1858.
51. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 1994;179:1109-1118.
52. Porcelli S, Brenner MB, Greenstein JL, Balk SP, Terhorst C, Bleicher PA. Recognition of cluster of differentiation 1 antigens by human CD4-CD8-cytolytic T lymphocytes. Nature 1989;341:447-450.
53. Buettner M, et al. Inverse correlation of maturity and antibacterial activity in human dendritic cells. J Immunol 2005;174:4203-4209.
54. Moody DB, Porcelli SA. CD1 trafficking: invariant chain gives a new twist to the tale. Immunity 2001;15:861-865.
55. Dascher CC, Brenner MB. CD1 antigen presentation and infectious disease. Contrib Microbiol 2003;10:164-182.
56. Jayawardena-Wolf J, Benlagha K, Chiu YH, Mehr R, Bendelac A. CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 2001;15:897-908.
57. Briken V, Jackman RM, Dasgupta S, Hoening S, Porcelli SA. Intracellular trafficking pathway of newly synthesized CD1b molecules. EMBO J 2002;21:825-834.
58. Yuan W, Kang SJ, Evans JE, Cresswell P. Natural lipid ligands associated with human CD1d targeted to different subcellular compartments. J Immunol 2009;182:4784-4791.
59. Cox D, et al. Determination of cellular lipids bound to human CD1d molecules. PLoS ONE 2009;4:e5325.
60. Huang S, et al. Discovery of deoxyceramides and diacylglycerols as CD1b scaffold lipids among diverse groove-blocking lipids of the human CD1 system. Proc Natl Acad Sci USA 2011;108:19335-19340.
61. Haig NA, Guan Z, Li D, McMichael A, Raetz CR, Xu XN. Identification of self-lipids presented by CD1c and CD1d proteins. J Biol Chem 2011;286:37692-37701.
62. Sugita M, et al. Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICs. Science 1996;19:349-352.
63. Jackman RM, et al. The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens. Immunity 1998;8:341-351.
64. Sugita M, et al. Separate pathways for antigen presentation by CD1 molecules. Immunity 1999;11:743-752.
65. Briken V, Jackman RM, Watts GF, Rogers RA, Porcelli SA. Human CD1b and CD1c isoforms survey different intracellular compartments for the presentation of microbial lipid antigens. J Exp Med 2000;192:281-288.
66. Sugita M, van Der WN, Rogers RA, Peters PJ, Brenner MB. CD1c molecules broadly survey the endocytic system. Proc Natl Acad Sci USA 2000;97:8445-8450.
67. Barral DC, et al. CD1a and MHC class I follow a similar endocytic recycling pathway. Traffic 2008;9:1146-1157.
68. Manolova V, et al. Functional CD1a is stabilized by exogenous lipids. Eur J Immunol 2006;36:1083-1092.
69. Moody DB, et al. Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation. Nat Immunol 2002;3:435-442.
70. Sturgill-Koszycki S, et al. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 1994;263:678-681.
71. Xu S, et al. Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages. J Immunol 1994;153:2568-2578.
72. Schaible UE, Hagens K, Fischer K, Collins HL, Kaufmann SH. Intersection of group I CD1 molecules and mycobacteria in different intracellular compartments of dendritic cells. J Immunol 2000;164:4843-4852.
73. Beatty WL, Rhoades ER, Ullrich HJ, Chatterjee D, Heuser JE, Russell DG. Trafficking and release of mycobacterial lipids from infected macrophages. Traffic 2000;1:235-247.
74. Hava DL, et al. Evasion of peptide, but not lipid antigen presentation, through pathogen-induced dendritic cell maturation. Proc Natl Acad Sci USA 2008;105:11281-11286.
75. Kasmar A, et al. CD1a tetramers and dextramers identify human lipopeptide-specific T cells ex vivo. J Immunol 2013;191:4499-4503.
76. van den Elzen P, et al. Apolipoprotein-mediated pathways of lipid antigen presentation. Nature 2005;437:906-910.
77. Prigozy TI, et al. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity 1997;6:187-197.
78. Kang PB, et al. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J Exp Med 2005;202:987-999.
79. Tailleux L, et al. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med 2003;197:121-127.
80. Yadav M, Schorey JS. The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. Blood 2006;108:3168-3175.
81. Cywes C, Hoppe HC, Daffe M, Ehlers MR. Nonopsonic binding of Mycobacterium tuberculosis to complement receptor type 3 is mediated by capsular polysaccharides and is strain dependent. Infect Immun 1997;65:4258-4266.
82. Hunger RE, et al. Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. J Clin Invest 2004;113:701-708.
83. Mukherjee S, Soe TT, Maxfield FR. Endocytic sorting of lipid analogues differing solely in the chemistry of their hydrophobic tails. J Cell Biol 1999;144:1271-1284.
84. Prigozy TI, et al. Glycolipid antigen processing for presentation by CD1d molecules. Science 2001;291:664-667.
85. Cala-De Paepe D, et al. Deciphering the role of CD1e protein in mycobacterial phosphatidyl-myo-inositol mannosides (PIM) processing for presentation by CD1b to T lymphocytes. J Biol Chem 2012;287:31494-31502.
86. Ly D, et al. CD1c tetramers detect ex vivo T cell responses to processed phosphomycoketide antigens. J Exp Med 2013;210:729-741.
87. Cheng TY, et al. Role of lipid trimming and CD1 groove size in cellular antigen presentation. EMBO J 2006;25:2989-2999.
88. Kang SJ, Cresswell P. Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells. Nat Immunol 2004;5:175-181.
89. Winau F, et al. Saposin C is required for lipid presentation by human CD1b. Nat Immunol 2004;5:169-174.
90. Zhou D, et al. Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 2004;303:523-527.
91. Kaser A, et al. Microsomal triglyceride transfer protein regulates endogenous and exogenous antigen presentation by group 1 CD1 molecules. Eur J Immunol 2008;38:2351-2359.
92. Layre E, et al. Mycolic acids constitute a scaffold for mycobacterial lipid antigens stimulating CD1-restricted T cells. Chem Biol 2009;16:82-92.
93. Batuwangala T, et al. The crystal structure of human CD1b with a bound bacterial glycolipid. J Immunol 2004;172:2382-2388.
94. Van Rhijn I, et al. TCR bias and affinity define two compartments of the CD1b-glycolipid-specific T cell repertoire. J Immunol 2014;193:5338-5344.
95. Garcia-Alles LF, et al. Structural reorganization of the antigen-binding groove of human CD1b for presentation of mycobacterial sulfoglycolipids. Proc Natl Acad Sci USA 2011;108:17755-17760.
96. Guiard J, et al. Fatty acyl structures of mycobacterium tuberculosis sulfoglycolipid govern T cell response. J Immunol 2009;182:7030-7037.
97. Gau B, et al. Simplified deoxypropionate acyl chains for Mycobacterium tuberculosis sulfoglycolipid analogues: chain length is essential for high antigenicity. ChemBioChem 2013;14:2413-2417.
98. Gadola SD, et al. Structure of human CD1b with bound ligands at 2.3 A, a maze for alkyl chains. Nat Immunol 2002;3:721-726.
99. Wu D, et al. Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d. Proc Natl Acad Sci USA 2006;103:3972-3977.
100. Garcia-Alles LF, et al. Endogenous phosphatidylcholine and a long spacer ligand stabilize the lipid-binding groove of CD1b. EMBO J 2006;25:3684-3692.
101. Scharf L, et al. The 2.5 a structure of CD1c in complex with a mycobacterial lipid reveals an open groove ideally suited for diverse antigen presentation. Immunity 2010;33:853-862.
102. Moody DB, et al. CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature 2000;20:884-888.
103. Matsunaga I, et al. Mycobacterium tuberculosis pks12 produces a novel polyketide presented by CD1c to T cells. J Exp Med 2004;200:1559-1569.
104. Crich D, Dudkin V. Confirmation of the connectivity of 4, 8, 12, 16, 20-pentamethylpentacosylphoshoryl beta-D-mannopyranoside, an unusual beta-mannosyl phosphoisoprenoid from Mycobacterium avium, through synthesis. J Am Chem Soc 2002;124:2263-2266.
105. van Summeren RP, Moody DB, Feringa BL, Minnaard AJ. Total synthesis of enantiopure beta-D-mannosyl phosphomycoketides from Mycobacterium tuberculosis. J Am Chem Soc 2006;128:4546-4547.
106. Li NS, Scharf L, Adams EJ, Piccirilli JA. Highly stereocontrolled total synthesis of beta-D-mannosyl phosphomycoketide: a natural product from Mycobacterium tuberculosis. J Org Chem 2013;78:5970-5986.
107. de Jong A, et al. CD1c presentation of synthetic glycolipid antigens with foreign alkyl branching motifs. Chem Biol 2007;14:1232-1242.
108. Sirakova TD, Dubey VS, Kim HJ, Cynamon MH, Kolattukudy PE. The largest open reading frame (pks12) in the Mycobacterium tuberculosis genome is involved in pathogenesis and dimycocerosyl phthiocerol synthesis. Infect Immun 2003;71:3794-3801.
109. Farhat MR, et al. Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis. Nat Genet 2013;45:1183-1189.
110. Matsunaga I, Maeda S, Nakata N, Fujiwara N. The polyketide synthase-associated multidrug tolerance in Mycobacterium intracellulare clinical isolates. Chemotherapy 2012;58:341-348.
111. Philalay JS, Palermo CO, Hauge KA, Rustad TR, Cangelosi GA. Genes required for intrinsic multidrug resistance in Mycobacterium avium. Antimicrob Agents Chemother 2004;48:3412-3418.
112. + αβ T cell pool. J Immunol 1999;162:366-371.
113. Zajonc DM, et al. Molecular mechanism of lipopeptide presentation by CD1a. Immunity 2005;22:209-219.
114. Young DC, et al. Synthesis of dideoxymycobactin antigens presented by CD1a reveals T cell fine specificity for natural lipopeptide structures. J Biol Chem 2009;284:25087-25096.
115. Crellin P, Luo C, Morita YS. Metabolism of plasma membrane lipids in mycobacteria and corynebacteria. Lipid Metabolism, Prof. Rodrigo Valenzuela Baez ed. InTech. 2013. Available from http://www.intechopen.com/books/lipid-metabolism/metabolism-of-plasma-membrane-lipids-in-mycobacteria-and-corynebacteria.
116. Mishra AK, Driessen NN, Appelmelk BJ, Besra GS. Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction. FEMS Microbiol Rev 2011;35:1126-1157.
117. Gibson KJ, Gilleron M, Constant P, Puzo G, Nigou J, Besra GS. Structural and functional features of Rhodococcus ruber lipoarabinomannan. Microbiology 2003;149:1437-1445.
118. Ernst WA, et al. Molecular interaction of CD1b with lipoglycan antigens. Immunity 1998;8:331-340.
119. + T cells in the CD1-restricted repertoire: derivation of mycobacteria-reactive T cells from leprosy lesions. J Immunol 2000;164:4790-4796.
120. Fischer K, et al. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc Natl Acad Sci USA 2004;101:10685-10690.
121. Zajonc DM, Ainge GD, Painter GF, Severn WB, Wilson IA. Structural characterization of mycobacterial phosphatidylinositol mannoside binding to mouse CD1d. J Immunol 2006;177:4577-4583.
122. Torrelles JB, et al. Structural differences in lipomannans from pathogenic and nonpathogenic mycobacteria that impact CD1b-restricted T cell responses. J Biol Chem 2011;286:35438-35446.
123. Tatituri RV, et al. Recognition of microbial and mammalian phospholipid antigens by NKT cells with diverse TCRs. Proc Natl Acad Sci USA 2013;110:1827-1832.
124. Gumperz JE, et al. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 2000;12:211-221.
125. Brigl M, et al. Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors. J Immunol 2006;176:3625-3634.
126. Mallevaey T, et al. A molecular basis for NKT cell recognition of CD1d-self-antigen. Immunity 2011;34:315-326.
127. Girardi E, et al. Crystal structure of bovine CD1b3 with endogenously bound ligands. J Immunol 2010;185:376-386.
128. Dieude M, et al. Cardiolipin binds to CD1d and stimulates CD1d-restricted gammadelta T cells in the normal murine repertoire. J Immunol 2011;186:4771-4781.
129. Martin LH, Calabi F, Milstein C. Isolation of CD1 genes: a family of major histocompatibility complex-related differentiation antigens. Proc Natl Acad Sci USA 1986;83:9154-9158.
130. Bradbury A, Belt KT, Neri TM, Milstein C, Calabi F. Mouse CD1 is distinct from and co-exists with TL in the same thymus. EMBO J 1988;7:3081-3086.
131. Han M, Hannick LI, DiBrino M, Robinson MA. Polymorphism of human CD1 genes. Tissue Antigens 1999;54:122-127.
132. Seshadri C, Shenoy M, Wells RD, Hensley-McBain T, Andersen-Nissen E, McElrath MJ, Cheng TY, Moody DB, Hawn TR. Human CD1a deficiency is common and genetically regulated. J Immunol 2013;191:1586-1593.
133. de Jong A, et al. CD1a-autoreactive T cells recognize natural skin oils that function as headless antigens. Nat Immunol 2014;15:177-185.
134. de Jong A, Pena-Cruz V, Cheng TY, Clark RA, Van Rhijn I, Moody DB. CD1a-autoreactive T cells are a normal component of the human αβ T cell repertoire. Nat Immunol 2010;11:1102-1109.
135. + mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection. PLoS ONE 2013;8:e83474.
136. Gold MC, et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol 2010;8:e1000407.
137. Le Bourhis L, et al. Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol 2010;11:701-708.
138. Altman JD, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996;274:94-96.
139. Casalegno-Garduno R, et al. Multimer technologies for detection and adoptive transfer of antigen-specific T cells. Cancer Immunol Immunother 2010;59:195-202.
140. Matsuda JL, et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med 2000;192:741-754.
141. Benlagha K, Weiss A, Beavis A, Teyton L, Bendelac A. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J Exp Med 2000;191:1895-1903.
142. Gadola SD, Dulphy N, Salio M, Cerundolo V. Vα24-JαQ-independent, CD1d-restricted recognition of α-galactosylceramide by human CD4(+) and CD8αβ (+) T lymphocytes. J Immunol 2002;168:5514-5520.
143. Gumperz JE, Miyake S, Yamamura T, Brenner MB. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med 2002;195:625-636.
144. Chackerian A, Alt J, Perera V, Behar SM. Activation of NKT cells protects mice from tuberculosis. Infect Immun 2002;70:6302-6309.
145. Kasmar AG, et al. CD1b tetramers bind αβ T cell receptors to identify a mycobacterial glycolipid-reactive T cell repertoire in humans. J Exp Med 2011;208:1741-1747.